Heparin or bivalirudin for non-primary PCI: Beware of neat and simple answers
.
Catheter Cardiovasc Interv
; 90(3): 378-379, 2017 09 01.
Article
in En
| MEDLINE
| ID: mdl-28891164
ABSTRACT
The debate regarding the choice of heparin or bivalirudin as the preferred anticoagulant in PCI is still ongoing Nonrandomized registry data are severely limited for comparative analyses and should therefore always be interpreted with caution Clinicians should resist simplistic data interpretations or populist cries relating to cost, but rather focus on valid benefitrisk analyses for their clinical decision making.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Heparin
/
Percutaneous Coronary Intervention
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Catheter Cardiovasc Interv
Journal subject:
CARDIOLOGIA
Year:
2017
Type:
Article